Saturday, 17 April 2010 03:37
JDRF who are working on an Artificial Pancreas for type 1 diabetes have announced they successful tested for safety and efficacy the use of an extra hormone 'glucagon', in addition to insulin. Glucagon is a naturally occurring hormone that raises blood sugars in response to hypoglycemia and is impaired in people with type 1 diabetes. The addition of glucagon to the closed-loop system was designed to more closely mimic the physiology of a person without diabetes. The trial was completed by researchers from Boston University and Massachusetts General Hospital.
Discuss this item on the forums. (0 posts)
With the release of the iPad, there is also a flood of new apps coming out for it. A lot of the top fitness apps for the iphone were based on pedometers and GPS tracking, so those functions aren't too practical with the bigger ipad. However, the bigger screen is a great platform for virtual training.
Rady Children’s Hospital in San Diego is the first U.S.-based pediatric specialty hospital to install the
The TandemHeart® extracorporeal circulatory support system has now been used in 2,000 cases. CardiacAssist who make the TandemHeart have said that it is being used in 90% of the “Best U.S. Heart Surgery Hospitals” as ranked by U.S. News World Report. More than 100 additional U.S. hospitals are considering TandemHeart purchases in this calendar year.
PinPointe USA, Inc.,has announced that it's 




